Global Pain Survey Finds a Consistent Sex Gap Across 11 Body Sites
A global analysis of self-reported pain has drawn a broad, uncomfortable conclusion: women report more pain than men across every body site examined. The dataset is enormous — 6,125,459 participants across 118 countries — and the pattern held across the head, face, neck and shoulder region, hand and wrist, elbows, feet and ankles, knees, chest, back, abdominal area, and hips. Back pain was the most common complaint overall, with a prevalence of 40%.
The breadth of the finding matters. This was not a narrow signal confined to one organ system or one age band; it appeared across multiple pain phenotypes and anatomical regions, suggesting a durable sex-associated difference in how pain is experienced, reported, or both.
Biology, Hormones, and Social Exposure All Likely Contribute
The mechanism is unlikely to be singular. Women consistently reported more pain, but the explanation almost certainly spans biology, behavior, and care access. Sex hormones, immune function, central nervous system pain processing, stress, reproductive burdens, occupational exposures, and differences in symptom reporting all sit plausibly inside the same causal frame.
Preclinical work supports the idea that pain biology can diverge by sex at the immune level. In animal models, males and females appear to recruit different immune pathways when pain sensitivity rises. One proposed distinction involves microglia in males and T-cell activity in females, a split that could help explain why a single analgesic strategy does not work equally well for every patient. Those findings remain largely rooted in rodent research, so translation to bedside care still requires caution.
The clinical pattern is especially pronounced in conditions such as migraine, temporomandibular pain, and visceral pain. Those syndromes cluster around the reproductive years, which makes pubertal development and hormonal cycling hard to ignore as contributors. Dysmenorrhea, endometriosis, and pelvic pain also add directly to the abdominal pain burden in women, while nociplastic pain mechanisms may amplify persistent, diffuse symptoms such as those seen in fibromyalgia.
One sentence captures the clinical sting of the paper: the sex gap was not confined to a single complaint, but ran through the whole pain map.
Cross-Sectional Data Point to Midlife as a High-Risk Window
The age pattern was equally important. Across sexes, the sharpest rise in pain prevalence occurred before age 55, especially between 20 and 55 years. That does not mean pain is highest before midlife. It means the proportion of people reporting pain increases most rapidly during those years, before later-life prevalence levels off or continues rising more gradually in some sites such as the back, hip, and knee.
The physiology behind that pattern is plausible even without a single definitive answer. Early and middle adulthood are the years when physical workload, injuries, weight gain, metabolic disease, stress, sleep disruption, and repetitive strain often accumulate. By later life, much of that burden may already be established, leaving a cohort of patients with entrenched musculoskeletal and nociceptive problems. In other words, pain risk may build quietly for decades before it becomes visible in a population estimate.
This is also where interpretation needs discipline. The data are cross-sectional, so they describe age patterns in populations rather than the trajectory of pain within individual people. The estimates also refer to point or period prevalence, not chronicity. In practical terms, the analysis captures who is reporting pain, not how long each episode has lasted or how severe it feels from day to day.
Preventing Pain May Need to Start Earlier Than Usual Care Pathways
The study pushes prevention toward earlier adulthood. If pain prevalence rises most quickly in the 20s through the 40s, then prevention cannot wait until geriatric care or late-stage musculoskeletal decline. That means clinicians may need to think about pain risk in the same way they think about cardiometabolic risk: as something shaped by cumulative exposures long before severe disability appears.
A targeted approach would begin with identifying treatable causes, then layering in movement-based rehabilitation, psychological therapy, and risk-factor modification. Exercise is central because it improves pain, function, and general health without requiring one superior modality to fit every patient. Cognitive behavioral therapy and acceptance and commitment therapy also deserve emphasis for chronic musculoskeletal pain because they alter pain processing in the nervous system rather than merely asking patients to endure symptoms more stoically.
The practical consequence is familiar to pain clinicians: the aim should not be total eradication of every sensation, because that is often unrealistic. Restoring function, mobility, work capacity, and daily activity is usually a more meaningful clinical endpoint.
Data Gaps Leave Much of the World Underrepresented
The global scale of the analysis makes its geographic blind spots harder to ignore. Suitable datasets were difficult to identify and access in lower-HDI regions, especially parts of sub-Saharan Africa, Southeast Asia, and other underrepresented settings. The obstacles were not mysterious: limited data collection, fewer large cohort studies, resource constraints for storage and maintenance, limited research infrastructure, and barriers to secondary analysis.
Those gaps matter because pain burden is not evenly distributed, and neither are the systems used to measure it. Without stronger datasets from low-resource settings, estimates of global pain prevalence will continue to lean heavily on regions with better surveillance and larger research capacity. That can distort age curves, obscure sex differences, and weaken prevention strategies built on incomplete evidence.
A sentence of warning belongs here as well: the countries with the weakest data may be the ones where the greatest burden remains least visible.
What Clinicians Should Tell Patients With Chronic Pain
For people already living with persistent pain, the bedside message should be direct. Do not simply normalize it, and do not assume medication alone will solve it. A thorough evaluation is still the first step, because treatment depends on identifying the pain type and source as precisely as possible.
From there, the focus shifts to function. Physical therapy, exercise, behavioral strategies, mindfulness-based approaches, and medication when appropriate can all play a role, but the mix should reflect the individual patient’s pain generator, comorbidities, and goals. Sleep, smoking, weight, and mood deserve active attention because each can influence pain intensity and quality.
The data do not suggest that women are somehow more fragile or that men are immune to chronic pain. They do suggest that pain surveillance, prevention, and treatment need to reflect sex differences, lifespan timing, and social context more honestly than many current care pathways do.